| Title |
Incidence of WHO Stage 3 and 4 Conditions following Initiation of Anti-Retroviral Therapy in Resource Limited Settings
|
|---|---|
| Published in |
PLOS ONE, December 2012
|
| DOI | 10.1371/journal.pone.0052019 |
| Pubmed ID | |
| Authors |
Andrea J. Curtis, Catherine S. Marshall, Tim Spelman, Jane Greig, Julian H. Elliot, Leslie Shanks, Philipp Du Cros, Esther C. Casas, Marcio Silveria Da Fonseca, Daniel P. O’Brien |
| Abstract |
To determine the incidence of WHO clinical stage 3 and 4 conditions during early anti-retroviral therapy (ART) in resource limited settings (RLS). |
X Demographics
The data shown below were collected from the profiles of 6 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Canada | 1 | 17% |
| United States | 1 | 17% |
| South Africa | 1 | 17% |
| United Kingdom | 1 | 17% |
| Unknown | 2 | 33% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 4 | 67% |
| Scientists | 1 | 17% |
| Practitioners (doctors, other healthcare professionals) | 1 | 17% |
Mendeley readers
The data shown below were compiled from readership statistics for 75 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Indonesia | 1 | 1% |
| India | 1 | 1% |
| France | 1 | 1% |
| Unknown | 72 | 96% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Student > Master | 17 | 23% |
| Researcher | 13 | 17% |
| Other | 7 | 9% |
| Student > Ph. D. Student | 6 | 8% |
| Student > Bachelor | 4 | 5% |
| Other | 15 | 20% |
| Unknown | 13 | 17% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 37 | 49% |
| Social Sciences | 5 | 7% |
| Nursing and Health Professions | 3 | 4% |
| Agricultural and Biological Sciences | 3 | 4% |
| Immunology and Microbiology | 3 | 4% |
| Other | 8 | 11% |
| Unknown | 16 | 21% |